Myeloid neoplasms arise from malignant primitive cells, which exhibit growth advantage
within the bone marrow microenvironment (BMM). The interaction between these malignant …

Simple Summary Since the discovery of the role of the three driver mutations (JAK2, CALR
and MPL) and the constitutive activation of the JAK/STAT pathway in myeloproliferative …

The capacity of the human microbiome to modulate inflammation in the context of cancer is
becoming increasingly clear. Myeloproliferative neoplasms (MPNs) are chronic hematologic …

Essential thrombocythemia (ET) is part of the Philadelphia chromosome-negative
myeloproliferative neoplasms. It is characterized by an increased risk of thromboembolic …

Background Essential thrombocythemia (ET), polycythemia vera (PV), and primary
myelofibrosis (MF) are myeloproliferative neoplasms (MPN). Inflammation is involved in the …

Abstract The MPL W515L mutation is a prevalent genetic mutation in patients with
myeloproliferative neoplasms (MPN), and utilizing this mutation in mice model can provide …

Chronic inflammation is believed to play an important role in the development and disease
progression of polycythemia vera (PV). Because an association between gut microbiota …

Gut microbiota and myeloproliferative neoplams Gut microbiota and myeloproliferative neoplams
J Pak Med Assoc. 2023 Dec;73(12):2334-2336. doi: 10.47391/JPMA.23-99. Authors Adeniyi …